Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta for COVID-19 Treatment
The Pharma Data
OCTOBER 18, 2020
An ISO 13485-certified company operating in line with cGMP guidelines and international standards, Akron leverages more than 100,000 square feet of development and manufacturing capacity to provide therapy developers the scale, compliance, and regulatory support necessary to drive novel treatments from discovery to commercialization.
Let's personalize your content